Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-5370

ABSTRACT: Transcription profiling of human muscle biopsies from pre-treatment dermatomyostitis patients vs. normal controls to define molecular pathways in muscle of myositis patients.

PROVIDER: E-GEOD-5370 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-5370-analysis-methods.tsv	Tabular
	E-GEOD-5370-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-5370-configuration.xml	Xml
	E-GEOD-5370-percentile-ranks.tsv	Tabular
	E-GEOD-5370.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 49

Similar Datasets

E-MTAB-57

Project description:Transcription profiling of colon cancer tumor and normal biopsies from a series of patients to identify molecular biomarkers

2025-01-23 | E-MTAB-57 | ExpressionAtlas

E-GEOD-9493

Project description:Transcriptomic analyses of renal allograft biopsies reveal conserved rejection signatures and molecular pathways

2025-01-24 | E-GEOD-9493 | ExpressionAtlas

E-GEOD-6364

Project description:Transcription profiling of human endometrium from patients with a history of endometriosis vs. normal controls sampled at a range of menstrual cycle timepoints

2025-01-24 | E-GEOD-6364 | ExpressionAtlas

E-GEOD-46239

Project description:Transcription profiling by array of skin biopsies from dermatomyositis patients and healthy controls

2025-01-24 | E-GEOD-46239 | ExpressionAtlas

Expression data from inflammatory myopathies

Project description:MHC-I overexpression in muscle biopsies is a hallmark of inflammatory myopathies.However the mechanisms of MHC-I overexpression in each disease is not well understood. Microarray analysis from MHC-I-microdissected myofibers showed a differential expression signature in each inflammatory myopathy. Innate immunity and IFN-I pathways are upregulated vs healthy controls, specifically in dermatomyositis (DM). RNA from MHC-I-positive myofibers were obtained from muscle biopsies of 5 patients with dermatomyositis, 5 with polymyositis, 4 with inclusion body myositis and normal looking fibers from healthy controls.

2013-12-01 | E-GEOD-48280 | biostudies-arrayexpress

E-GEOD-65114

Project description:Microarray analysis of colonic mucosal biopsies from healthy controls and patients with active ulcerative colitis

2025-01-24 | E-GEOD-65114 | ExpressionAtlas

Transcription profiling of human muscle biopsies from pre-treatment dermatomyostitis patients vs. normal controls to define molecular pathways in muscle of myositis patients.

Project description:Idiopathic inflammatory myopathies (polymyositis and dermatomyositis) are heterogeneous group of muscle disorders of unknown etiology.The pathogenic pathways responsible for muscle fiber damage and dysfunction in myositis are not currently well defined. Identification of such pathways may help to design novel therapeutic interventions and also help to develop diagnostic tests. Experiment Overall Design: Muscle biopsies from a separate group of 5 adult untreated female DM patients were profiled and compared to muscle tissue of normal human healthy volunteers to define molecular pathways in muscle of myositis patients. Confirm and map key pathway members to specific cell types in the muscle tissue of patients and controls using RT-PCR, Western blotting and Immunolocalization.

2007-10-26 | E-GEOD-5370 | biostudies-arrayexpress

E-GEOD-6475

Project description:Transcription profiling of human acne lesion vs. normal skin from acne and non acne patients

2025-01-24 | E-GEOD-6475 | ExpressionAtlas

E-MEXP-2280

Project description:Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways

2025-01-22 | E-MEXP-2280 | ExpressionAtlas

E-MTAB-5262

Project description:Investigation of gene expression in biopsies from psoriasis patients before and after adalimumab treatment. Paired biopsies from non-lesional and lesional before treatment start and from psoriatic skin four and 14 days treatment start were included.

2025-01-23 | E-MTAB-5262 | ExpressionAtlas

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data